2023 Diabetes Highlights & Headway

2023 Diabetes Highlights

2023 was a big year in the world of diabetes, from the FDA’s approval of a new bionic pancreas to promising cell therapy trial results, and lots of stuff in between. It’s easy to forget how far we’ve come in such a short period of time, so here’s a recap of several key advancements that were made this year.

read more

Thank You for Making a Difference!

As we near the end of 2023, Drs. E+P would like to thank you for being part of the TCOYD community and helping in our mission to educate, motivate, and empower people with diabetes around the world. Your support has improved the lives of millions of people, including many who don’t have regular access to diabetes education and resources. With your help, we’ve reached over 10 million people from 50 states and over 200 countries this year, and we plan to reach even more people in 2024.

read more

This Diabetes Awareness Month, Don’t Forget about the Things You Do RIGHT!

A Dose of Dr. E and P

How often do you celebrate your wins with diabetes? Have you ever? Take a moment and pat yourself on the back for all the things you manage on a daily basis. Woke up with a decent blood sugar? Nailed a bolus? Took a walk around the block instead of watching Seinfeld? Drs. E+P remind us how important it is to celebrate our victories, big and small.

read more

Tzield Shows Promise in Treating Newly Diagnosed T1D

Tzield News

Recently released data from Tzield’s PROTECT study showed that Tzield significantly slowed the decline of C-peptide levels in children and adolescents with newly diagnosed type 1 diabetes. Further data showed that study participants on Tzield required numerically fewer insulin units and had numerically higher time in range compared to those on placebo.

read more